HIGHLIGHTS
- who: Yandy Marx Castillo-Aleman from the Kanazawa University, Japan have published the paper: Beyond 8-methoxypsoralen as the photosensitizer for extracorporeal photopheresis, in the Journal: (JOURNAL)
- what: Additional developments in manufacturing and evaluating innovative ECP-photosensitizing drugs are rising needs that should accompany the development of photopheresis medical devices.
- future: Preclinical research is needed to clarify ECP mechanisms of action resulting in appropriate harmonized quality_controls for these photosensitizers. Still more clinical studies are required to demonstrate differences in safety efficacy and cost profiles compared to the approved 8-MOP.
SUMMARY . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.